TherapeuticsMD Inc (TXMD)
2.03
0.00 (0.00%)
USD |
NASDAQ |
May 10, 16:00
2.03
0.00 (0.00%)
After-Hours: 17:51
TherapeuticsMD Free Cash Flow: -23.08M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -23.08M |
| September 30, 2023 | -1.322M |
| June 30, 2023 | 22.42M |
| March 31, 2023 | 5.093M |
| December 31, 2022 | -4.433M |
| September 30, 2022 | -62.23M |
| June 30, 2022 | -118.36M |
| March 31, 2022 | -124.18M |
| December 31, 2021 | -144.92M |
| September 30, 2021 | -134.69M |
| June 30, 2021 | -130.60M |
| March 31, 2021 | -160.33M |
| December 31, 2020 | -161.07M |
| September 30, 2020 | -201.75M |
| June 30, 2020 | -194.96M |
| March 31, 2020 | -190.31M |
| December 31, 2019 | -189.59M |
| September 30, 2019 | -146.71M |
| June 30, 2019 | -173.59M |
| March 31, 2019 | -147.14M |
| December 31, 2018 | -128.13M |
| September 30, 2018 | -120.64M |
| June 30, 2018 | -82.99M |
| March 31, 2018 | -76.14M |
| December 31, 2017 | -76.98M |
| Date | Value |
|---|---|
| September 30, 2017 | -71.84M |
| June 30, 2017 | -74.07M |
| March 31, 2017 | -71.48M |
| December 31, 2016 | -70.38M |
| September 30, 2016 | -71.43M |
| June 30, 2016 | -70.92M |
| March 31, 2016 | -80.01M |
| December 31, 2015 | -79.63M |
| September 30, 2015 | -78.25M |
| June 30, 2015 | -71.21M |
| March 31, 2015 | -56.50M |
| December 31, 2014 | -46.14M |
| September 30, 2014 | -35.43M |
| June 30, 2014 | -29.45M |
| March 31, 2014 | -26.46M |
| December 31, 2013 | -21.25M |
| September 30, 2013 | -20.40M |
| June 30, 2013 | -18.06M |
| March 31, 2013 | -14.13M |
| December 31, 2012 | -13.01M |
| September 30, 2012 | -10.78M |
| June 30, 2012 | -9.181M |
| March 31, 2012 | -6.729M |
| December 31, 2011 | -5.004M |
| September 30, 2011 | -3.333M |
Free Cash Flow Range, Past 5 Years
-201.75M
Minimum
Sep 2020
22.42M
Maximum
Jun 2023
-112.35M
Average
-134.69M
Median
Sep 2021
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.20M |
| Oragenics Inc | -7.291M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.96M |
| Cash from Financing (Quarterly) | 2.002M |
| Free Cash Flow Per Share (Quarterly) | -0.4492 |
| Free Cash Flow to Equity (Quarterly) | -4.96M |
| Free Cash Flow Yield | -109.0% |